Canopy Growth Corporation (TSX: WEED) Stock Analysis & Fundamentals

WEEDCanopy Growth Corporation

TSX · CA · Healthcare · Drug Manufacturers - Specialty & Generic · canopygrowth.com

1.460CAD+5.80%Mkt Cap: 477.94M $P/E: —Today

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and …

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.24BUSDP/E 23.7

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

$15.39BUSDP/E 118.0

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporat

Hims & Hers Health, Inc.

Lantheus Holdings Inc

$6.56BUSDP/E 24.0

AMRX

Amneal Pharmaceuticals, Inc.

$6.23BUSDP/E 37.3

INDV

Indivior PLC Ordinary Shares

$4.61BUSDP/E 14.0

HIK

Hikma Pharmaceuticals PLC

$4.32BUSDP/E 12.5

AMLX

Amylyx Pharmaceuticals Inc. Common Stock

Laboratorios Farmaceuticos Rovi, S.A.

$3.34BUSDP/E 16.6

SUPN

Supernus Pharmaceuticals, Inc.

$2.82BUSD

Key Statistics

Company

Market Cap477.94M $

Enterprise Value402.68M $

Revenue (TTM)213.84M $

Gross Profit50.74M $

Net Income (TTM)-191.47M $

Revenue/Share0.6001 USD

Last Price1.460 CAD

Fiscal Year EndMar 2026

MR QuarterJun 2026

Employees1.1K

CountryCA

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISINCA1380351009

Valuation

P/E (Trailing)—

P/E (Forward)-8.53

PEG—

EV/EBITDA-21.18

EV/Revenue1.88

P/S2.35

P/B0.70

EPS (TTM)-0.67

EPS (Forward)-0.17

52W Range

1.18013% of range3.280

52W High3.280 CAD

52W Low1.180 CAD

Profitability

Gross Margin24.48%

Oper. Margin-21.66%

EBITDA Margin-8.89%

Profit Margin-92.38%

ROE-37.69%

ROA-23.50%

Growth

Revenue Growth12.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF-46.47M $

CapEx (TTM)4.34M $

FCF Margin2.45%

FCF Yield1.10%

Net Debt-44.04M $

Net Debt/EBITDA2.32

Balance Sheet

Debt/Equity0.40

Current Ratio3.04

Quick Ratio2.28

Book Value/Sh2.059 CAD

Cash/Share0.7990 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 CAD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:10

Split DateDec 20, 2023

Analyst Consensus

Rating2.5 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)2.020 CAD

Upside (mean)+38.4%

Target Range0.9400 CAD – 5.000 CAD

CAD0.9400+38.4% to meanCAD5.000

# Analysts7

Ownership

Shares Out.423.04M

Float422.23M

Insiders0.19%

Institutions7.92%

Short Interest

Short Ratio21.5d

Short % Float4.05%

Short % Out.4.04%

Shares Short17.07M

Short (prev mo.)16.51M

Technical

SMA 501.353 (+7.9%)

SMA 2001.518 (-3.8%)

Beta2.41

S&P 52W Chg18.16%

Avg Vol (30d)798.52K

Avg Vol (10d)1.06M

Technical Indicators

RSI (14)54.2

MACD0.0095

MACD Signal-0.0061

MACD Hist.+0.0156

BB Upper1.422 CAD

BB Middle1.322 CAD

BB Lower1.222 CAD

BB Width15.20%

ATR (14)0.0555 CAD

Vol Ratio (20d)0.60x